Moreover, low expression of PCYT1B was accompanied by a corresponding increase in LD accumulation, suggesting that inhibition of PCYT1B is compatible with tumor initiation in the absence of p53 and may promote the accumulation of LDs in normal hepatocytes that facilitate tumorigenesis from an early time. Here, PCYT1B is linked to neoplasm.